Trial Profile
Relapse prevention of bipolar type-II disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2015
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Lithium (Primary)
- Indications Bipolar II disorders
- Focus Therapeutic Use
- 31 Mar 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
- 07 Feb 2007 Status changed from recruiting to in progress.
- 10 Dec 2005 New trial record.